Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
The company is rolling out ARTEMIS, a next-generation AI platform for capsid design
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
The partnership aims to develop a first-in-class broad-spectrum antifungal to combat life-threatening invasive infections
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
Subscribe To Our Newsletter & Stay Updated
